We are live on ! Find out more
IDIX

IDENIX PHARMACEUTICALS INC
IDIX

Delisted

IDIX was delisted on the 5th of August, 2014.

97 hedge funds and large institutions have $357M invested in IDENIX PHARMACEUTICALS INC in 2013 Q2 according to their latest regulatory filings, with 97 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more call options, than puts

Call options by funds: $4.01M | Put options by funds: $1.46M

Holders
97
Holders Change
+97
Holders Change %
% of All Funds
3.16%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
97
Increased
Reduced
Closed
Calls
$4.01M
Puts
$1.46M
Net Calls
+$2.55M
Net Calls Change
+$2.55M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
U
26
UBS
Switzerland
$2.13M +$2.41M +589,253 New
Millennium Management
27
Millennium Management
New York
$1.85M +$2.09M +511,831 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.63M +$1.85M +452,605 New
Geode Capital Management
29
Geode Capital Management
Massachusetts
$1.5M +$1.7M +415,232 New
TCIM
30
TIAA CREF Investment Management
New York
$1.48M +$1.67M +408,713 New
Deutsche Bank
31
Deutsche Bank
Germany
$1.04M +$1.19M +289,858 New
BIM
32
BlackRock Investment Management
Delaware
$985K +$1.12M +272,735 New
Charles Schwab
33
Charles Schwab
California
$896K +$1.02M +249,541 New
Macquarie Group
34
Macquarie Group
Australia
$812K +$920K +225,000 New
TD Asset Management
35
TD Asset Management
Ontario, Canada
$700K +$793K +193,900 New
AllianceBernstein
36
AllianceBernstein
Tennessee
$635K +$719K +175,791 New
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$628K +$711K +173,864 New
Wellington Management Group
38
Wellington Management Group
Massachusetts
$556K +$630K +154,000 New
Morgan Stanley
39
Morgan Stanley
New York
$538K +$610K +149,082 New
Goldman Sachs
40
Goldman Sachs
New York
$530K +$601K +146,942 New
JP Morgan Chase
41
JP Morgan Chase
New York
$522K +$591K +144,459 New
CS
42
Credit Suisse
Switzerland
$511K +$579K +141,681 New
TA
43
Teachers Advisors
New York
$452K +$512K +125,215 New
CNB
44
City National Bank
California
$438K +$496K +121,285 New
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$385K +$437K +106,772 New
Swiss National Bank
46
Swiss National Bank
Switzerland
$378K +$428K +104,700 New
QF
47
QVT Financial
New York
$361K +$409K +100,000 New
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$338K +$383K +93,643 New
ProShare Advisors
49
ProShare Advisors
Maryland
$304K +$344K +84,120 New
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$298K +$337K +82,360 New

IDIX Hedge Fund Activity: Q2 2013 in Review

97 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in IDENIX PHARMACEUTICALS INC (IDIX) for Q2 2013, worth a combined $357M.

Buyers outnumbered sellers: 97 funds opened new IDIX positions and 0 closed out — a net gain of 97 holders — while 0 added to existing stakes and 0 trimmed.

  • 97 institutional investors held IDENIX PHARMACEUTICALS INC (IDIX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $357M of IDENIX PHARMACEUTICALS INC stock for Q2 2013.
  • 97 funds opened new IDENIX PHARMACEUTICALS INC positions in Q2 2013 and 0 closed out, a net change of +97 holders.

Based on aggregated 13F filings for Q2 2013.